» Authors » Jennifer L Kemppainen

Jennifer L Kemppainen

Explore the profile of Jennifer L Kemppainen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 21
Citations 102
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Bandel L, Vierkant R, Kruisselbrink T, Bublitz M, Wilson T, Armasu S, et al.
Mayo Clin Proc . 2024 Dec; PMID: 39625429
Objective: To execute a large-scale, decentralized, clinical-grade whole exome sequencing study, coined Tapestry, for clinical practice, research discovery, and genomic education. Patients And Methods: Between July 1, 2020, and May...
2.
Samadder N, Gay E, Lindpere V, Bublitz M, Bandel L, Armasu S, et al.
JCO Precis Oncol . 2024 Jul; 8:e2400106. PMID: 39013133
Purpose: The autosomal dominant cancer predisposition disorders hereditary breast and ovarian cancer (HBOC) and Lynch syndrome (LS) are genetic conditions for which early identification and intervention have a positive effect...
3.
Wilke M, Klee E, Dhamija R, Fervenza F, Thomas B, Leung N, et al.
Orphanet J Rare Dis . 2024 May; 19(1):216. PMID: 38790019
Background: Though next-generation sequencing (NGS) tests like exome sequencing (ES), genome sequencing (GS), and panels derived from exome and genome data (EGBP) are effective for rare diseases, the ideal diagnostic...
4.
Pinto E Vairo F, Kemppainen J, Vitek C, Whalen D, Kolbert K, Sikkink K, et al.
J Transl Med . 2024 Apr; 22(1):400. PMID: 38689323
No abstract available.
5.
Pinto E Vairo F, Kemppainen J, Vitek C, Whalen D, Kolbert K, Sikkink K, et al.
J Transl Med . 2023 Jun; 21(1):410. PMID: 37353797
Background: In the United States, rare disease (RD) is defined as a condition that affects fewer than 200,000 individuals. Collectively, RD affects an estimated 30 million Americans. A significant portion...
6.
Chen X, Meyer M, Kemppainen J, Horibe M, Chandra S, Majumder S, et al.
JAMA Oncol . 2023 May; 9(7):955-961. PMID: 37200008
Importance: Increased cancer risk in first-degree relatives of probands with pancreatic ductal adenocarcinoma (PDAC probands) who carry pathogenic or likely pathogenic germline variants (PGVs) in cancer syndrome-associated genes encourages cascade...
7.
Klee E, Cousin M, Pinto E Vairo F, Morales-Rosado J, Macke E, Jenkinson W, et al.
Genet Med . 2023 Feb; 25(2):100359. PMID: 36745126
No abstract available.
8.
Rabe K, Stevens M, Hernandez A, Chandra S, Hubbard J, Kemppainen J, et al.
Genet Med . 2022 Mar; 24(5):1008-1016. PMID: 35227607
Purpose: Pancreatic cancer (PC) risk is increased in families, but PC risk and risk perception have been understudied when both parents have cancer. Methods: An unbiased method defining cancer triads...
9.
Schalk A, Cousin M, Dsouza N, Challman T, Wain K, Powis Z, et al.
J Med Genet . 2021 Dec; 59(10):965-975. PMID: 34930816
Background: High-impact pathogenic variants in more than a thousand genes are involved in Mendelian forms of neurodevelopmental disorders (NDD). Methods: This study describes the molecular and clinical characterisation of 28...
10.
Pinto E Vairo F, Prochnow C, Kemppainen J, Lisi E, Steyermark J, Kruisselbrink T, et al.
Kidney Med . 2021 Nov; 3(5):785-798. PMID: 34746741
Rationale & Objective: The etiology of kidney disease remains unknown in many individuals with chronic kidney disease (CKD). We created the Mayo Clinic Nephrology Genomics Clinic to improve our ability...